GLP-1 users face less hypoglycemia risk during exercise but may struggle with nausea if exercising too soon after injections
It has potent effects on blood glucose by either stimulating glucose-induced insulin release or inhibiting glucagon secretion [8, 9], and suppresses appetite via receptors in the ventral tegmental area, the nucleus accumbens and the hypothalamus (Fig
Users do not need to refrigerate the medication
Emergency surgeries proceed without delay, and your anesthesia team manages aspiration risk based on your current medication status
Persistent or worsening nausea beyond this timeframe should prompt reassessment for drug interactions, alternative diagnoses (e.g., gastroparesis), or consideration of anti-nausea medications
These receptor agonists are recognized for their cardioprotective properties and have been approved by the FDA to lower the risk of major adverse cardiovascular events in individuals who are overweight or obese with cardiovascular disease